bluebird bio (NASDAQ: BLUE) disclosed that partner Celgene Corporation (NASDAQ: CELG) has amended the study protocol for the KarMMa study ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE